Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propene SCHEMBL28953761 | 0.91 | HSD17B10 (0.42) | HSD17B10TDP1ALDH1A1TSHR | |
| SCHEMBL24321872 | 0.78 | HSD17B10 (0.41) | HSD17B10TDP1 | |
| SCHEMBL112173 | 0.76 | — | — | |
| SCHEMBL28814142 | 0.76 | TDP1 (0.52) | HSD17B10TDP1ALDH1A1TSHR | |
| SCHEMBL11554857 | 0.76 | — | — | |
| SCHEMBL28867903 | 0.76 | — | — | |
| SCHEMBL7261673 | 0.75 | ALDH1A1 (0.33) | HSD17B10ALDH1A1 | |
| SCHEMBL53 | 0.72 | ALDH1A1 (0.50) | HSD17B10TDP1ALDH1A1TSHR | |
| SCHEMBL4382071 | 0.72 | ALDH1A1 (0.50) | HSD17B10TDP1ALDH1A1TSHR | |
| Trifluoroacetic Acid SCHEMBL10398782 | 0.72 | ALDH1A1 (0.59) | HSD17B10TDP1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210332040-A1 | SUBSTITUTED 4-AMINO-1H-IMIDAZO[4,5-c]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION | INNATE TUMOR IMMUNITY INC (US) | 2021-10-28 | — | — | US | claimed |
| US-7807300-B2 | comprising an electron withdrawing group such as trifluoromethylvinyl acetate and 2,2,2-trifluoroacetamide, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, and an aromatic monoacid; for a battery cell in an implantable medical device | MEDTRONIC, INC. (US) | 2010-10-05 | — | — | US | claimed |
| US-20100136426-A1 | comprising an electron withdrawing group such as trifluoromethylvinyl acetate and 2,2,2-trifluoroacetamide, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, and an aromatic monoacid; for a battery cell in an implantable medical device | MEDTRONIC, INC. (US) | 2010-06-03 | — | — | US | claimed |
| US-20070178378-A1 | comprising an electron withdrawing group such as trifluoromethylvinyl acetate and 2,2,2-trifluoroacetamide, an aromatic diacid salt, an inorganic salt, an aliphatic organic acid, an aromatic diacid, and an aromatic monoacid; for a battery cell in an implantable medical device | MEDTRONIC, INC. | 2007-08-02 | — | — | US | claimed |
| EP-0592552-B1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES | DU PONT (US) | 1997-05-28 | — | — | EP | claimed |
| US-5559267-A | ENANTIOMORPHS, STEREOCHEMICAL CONTROL AND ASSYMETRIC INDUCTION, HYDROGENATION OF UNSATURATED ESTERS, COORDINATION CATALYSTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-09-24 | — | — | US | claimed |
| EP-0592552-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES. | DU PONT (US) | 1994-04-20 | — | — | EP | claimed |
| WO-1993001199-A1 | CHIRAL PHOSPHOLANES VIA CHIRAL 1,4-DIOL CYCLIC SULFATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-01-21 | — | — | WO | claimed |
| JP-62108845-A | — | — | None | — | — | JP | disclosed |
| WO-2025106690-A1 | PRECURSOR CONCENTRATION MONITORING | LAM RESEARCH CORPORATION (US) | 2025-05-22 | — | — | WO | disclosed |
| CN-118668496-A | Wear-resistant jean fabric and preparation method thereof | 佛山市南海雄科纺织有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-115101893-B | Method for preparing lithium battery diaphragm by using high melt index and low melt index polypropylene | 界首市天鸿新材料股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-11945890-B2 | Fluorinated PVC copolymer compositions for increased ultraviolet protection | Mexichem Specialty Resins Inc. (US) | 2024-04-02 | — | — | US | disclosed |
| WO-2024042043-A1 | A SCALABLE PROCESS FOR THE PREPARATION OF A GLYT-1 INHIBITOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| EP-0541395-B1 | Coating agents | TAKEMOTO OIL & FAT CO LTD (JP) | 1996-05-08 | — | — | EP | disclosed |
| US-5501904-A | POLYSILOXANE-VINYL GRAFT POLYMER | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 1996-03-26 | — | — | US | disclosed |
| US-5405691-A | Polysiloxane-polyvinyl graft copolymer | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0541395-A1 | Coating agents | Takemoto Yushi Kabushiki Kaisha (JP) | 1993-05-12 | — | — | EP | disclosed |
| JP-S62108845-A | PRODUCTION OF ALPHA-PERFLUOROALKYLVINYL ESTER | CENTRAL GLASS CO LTD | 1987-05-20 | — | — | JP | disclosed |
| US-4149010-A | Synthesis of α-trifluoromethyl vinyl acetate | POLAROID CORPORATION (US) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210332040-A1 | SUBSTITUTED 4-AMINO-1H-IMIDAZO[4,5-c]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION | NLRP3, NOD1, NLRP1 | HSD17B10 4099/4885TDP1 889/4885ALDH1A1 3065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.